1 - 10 of 39

Lisa MacDowell, MBA, CPA, CIA

Lisa MacDowell

Advances the Research Institute’s commitment to the development of shared resources that facilitate interdisciplinary research through numerous Core facilities that service both laboratory and clinical research programs.


Denise M. Melvin, MSM, RBP

Denise M. Melvin

Oversees three departments committed to the health and safety of Research Institute staff and serves as the Institutional Biosafety Officer.


Suzanne P. MacFarland, MD

Suzanne P. MacFarland Headshot

Dr. MacFarland's research focuses on syndromes that predispose to cancer development in children and adolescents. She has initiated several individual and collaborative research projects, working in pediatric polyposis syndromes and Li-Fraumeni syndrome. She is uncovering novel genomic drivers of disease and identifying biomarkers of cancer onset and progression.


Paris Margaritis, DPhil

Paris Margaritis

Dr. Margaritis uses biochemical, molecular, and complex in vivo methodology within the field of coagulation to advance the understanding of molecular mechanisms involved in pro- and anti-coagulant reactions, and translate research for the treatment of coagulation defects.


John M. Maris, MD

John M. Maris

Dr. Maris investigates the molecular and genetic mechanisms contributing to the development and progression of neuroblastoma, a common childhood cancer. He also aims to develop new molecular diagnostic tests and less toxic, targeted therapies to treat relapsed or refractory neuroblastoma, including a major effort in immunotherapy discovery and development.


Michael S. Marks, PhD

Michael S. Marks

Dr. Marks investigates the molecular mechanisms underlying the formation of cell type-specific lysosome-related organelles; the assembly, delivery and function of their contents; and how these processes are impacted by genetic diseases.


Eric D. Marsh, MD, PhD

Eric D. Marsh

Dr. Marsh's research program focuses on understanding how changes in brain development lead to epilepsy, intellectual disability, and autism. He combines molecular and physiological tools in mouse models to ask questions about the interaction of normal development with single gene mutations to determine how the brain responds to perturbations in development.